[HTML][HTML] Classification and epidemiology of vasculitis: Emerging concepts

T Ecclestone, RA Watts - Best Practice & Research Clinical Rheumatology, 2023 - Elsevier
The recent publication of the American College of Rheumatology (ACR)-European Alliance
of Associations for Rheumatology (EULAR) classification criteria for large vessel vasculitis …

[PDF][PDF] Systemic vasculitis: one year in review 2022

G La Rocca, G Del Frate, P Delvino… - Clin Exp …, 2022 - clinexprheumatol.org
Systemic vasculitis are rare heterogeneous disorders potentially involving any organ and
system with a relevant burden of mortality and comorbidity. As in the previous annual …

[HTML][HTML] Relationship between landscape and river ecosystem services

M Dede, S Sunardi, KC Lam… - Global Journal of …, 2023 - gjesm.net
Landscape dynamics are a consequence of population growth, which can degrade river
ecosystem services. Since various countries approved the millennium ecosystem …

[HTML][HTML] Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis

ME Wechsler, B Hellmich, MC Cid, D Jayne… - Journal of Allergy and …, 2023 - Elsevier
Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis
(EGPA) are rare systemic inflammatory disorders with overlapping symptoms, elevated …

Eosinophilic granulomatosis with polyangiitis

A Villa-Forte - Postgraduate Medicine, 2023 - Taylor & Francis
This review aims to describe the epidemiology, pathogenesis, clinical manifestations,
diagnosis, treatment, and prognosis of eosinophilic granulomatosis with polyangiitis (EGPA) …

Eosinophilic granulomatosis with polyangiitis

CR Gómez, HH Negrín, MMA Gutiérrez - Medicina Clínica (English Edition), 2023 - Elsevier
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized
by the presence of asthma associated with eosinophilia, eosinophilic infiltration of different …

Improving care in eosinophil-associated diseases: a charter

DJ Jackson, P Akuthota, R Andradas… - Advances in …, 2022 - Springer
Eosinophil-associated diseases (EADs) are a range of heterogeneous conditions in which
eosinophils are believed to play a critical pathological role. EADs include common illnesses …

[HTML][HTML] Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database

A Brailean, J Kwiatek, D Kielar, R Katial… - Allergy, Asthma & …, 2023 - ncbi.nlm.nih.gov
Purpose The epidemiology of eosinophil-associated diseases (EADs) is not yet fully
understood. While some studies have been conducted on stand-alone eosinophilic …

Trends in prevalence, treatment use, and disease burden in patients with eosinophilic granulomatosis with polyangiitis in Japan: real-world database analysis

K Sada, T Suzuki, S Joksaite, S Ju, J Logie… - Modern …, 2024 - academic.oup.com
Objectives We report the prevalence of eosinophilic granulomatosis with polyangiitis (EGPA)
and describe oral corticosteroid (OCS) use and disease burden before and after the …

Characteristics and disease burden of patients with eosinophilic granulomatosis with polyangiitis initiating mepolizumab in the United States

J Silver, A Deb, E Packnett, D McMorrow… - JCR: Journal of …, 2023 - journals.lww.com
Methods This was a database study (GSK study ID: 214156) of US patients (≥ 12 years old)
with EGPA and≥ 1 mepolizumab claim (index date) identified from the Merative MarketScan …